List of Tables
TABLE 1. RETINAL DISORDER TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DRY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY WET AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY NONPROLIFERATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY PROLIFERATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY BRANCH VEIN OCCLUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY CENTRAL VEIN OCCLUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY AFLIBERCEPT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY BEVACIZUMAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY BROLUCIZUMAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY RANIBIZUMAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DEXAMETHASONE IMPLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY FLUOCINOLONE ACETONIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY TRIAMCINOLONE ACETONIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY INTRAVITREAL INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY SUBRETINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY MULTISPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY INPATIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 77. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 78. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 79. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 80. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 81. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 82. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 83. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 84. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 87. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 88. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 90. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 91. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 92. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 93. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 95. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 96. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 99. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 100. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 152. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 153. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 154. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 155. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 156. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 157. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 160. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 161. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 163. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 164. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 165. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 166. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 167. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 168. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 169. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 170. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 172. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 173. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 187. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 188. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 189. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 190. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 191. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 192. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 193. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 194. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 196. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 197. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 199. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 200. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 201. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 202. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 203. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 204. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 205. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 208. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 209. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 247. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 248. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 249. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 250. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 251. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 252. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 253. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 254. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 256. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 257. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 271. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 272. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 273. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 274. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 275. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 276. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 277. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 278. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 280. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 281. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 283. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 284. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 285. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 286. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 287. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 288. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 289. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 290. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 292. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 293. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY ANTI-VEGF, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 304. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 305. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA RETINAL DISORDER TREATMENT MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA RETINAL DISORDER TREATMENT MARKET SIZE, BY RETINAL VEIN OCCLUSION, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD